Roda G - Search Results

1

Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?

D'Amico F, Roda G, Peyrin-Biroulet L, Danese S. D'Amico F, et al. Among authors: roda g. Curr Pharm Des. 2019;25(1):19-24. doi: 10.2174/1381612825666190307165703. Curr Pharm Des. 2019. PMID: 30848193 Review.

2

Biosimilars of adalimumab: the upcoming challenge in IBD.

Fiorino G, Gilardi D, Correale C, Furfaro F, Roda G, Loy L, Argollo M, Allocca M, Peyrin-Biroulet L, Danese S. Fiorino G, et al. Among authors: roda g. Expert Opin Biol Ther. 2019 Oct;19(10):1023-1030. doi: 10.1080/14712598.2019.1564033. Epub 2019 Jan 8. Expert Opin Biol Ther. 2019. PMID: 30601098 Review.

3

Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time?

Argollo M, Gilardi D, Roda G, Fiorino G, Peyrin-Biroulet L, Danese S. Argollo M, et al. Among authors: roda g. Curr Pharm Des. 2019;25(1):47-56. doi: 10.2174/1381612825666190308100844. Curr Pharm Des. 2019. PMID: 30848192 Review.

4

Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?

Argollo M, Fiorino G, Gilardi D, Furfaro F, Roda G, Loy L, Allocca M, Peyrin-Biroulet L, Danese S. Argollo M, et al. Among authors: roda g. Curr Pharm Des. 2019;25(1):7-12. doi: 10.2174/1381612825666190312113610. Curr Pharm Des. 2019. PMID: 30864505 Review.

5

Detection and management of early stage inflammatory bowel disease: an update for clinicians.

Loy L, Roda G, Fiorino G, Allocca M, Furfaro F, Argollo M, Peyrin-Biroulet L, Danese S. Loy L, et al. Among authors: roda g. Expert Rev Gastroenterol Hepatol. 2019 Jun;13(6):547-555. doi: 10.1080/17474124.2019.1605291. Epub 2019 Apr 22. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31007098 Review.

6

All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis.

Roda G, Lleo A, Danese S, Aghemo A. Roda G, et al. Clin Gastroenterol Hepatol. 2020 Jan;18(1):51-53. doi: 10.1016/j.cgh.2019.07.020. Epub 2019 Jul 16. Clin Gastroenterol Hepatol. 2020. PMID: 31323379 No abstract available.

7

Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs.

Roda G, Porru E, Katsanos K, Skamnelos A, Kyriakidi K, Fiorino G, Christodoulou D, Danese S, Roda A. Roda G, et al. Among authors: roda a. Cells. 2019 Aug 2;8(8):817. doi: 10.3390/cells8080817. Cells. 2019. PMID: 31382518 Free PMC article.

8

Modern use of 5-aminosalicylic acid compounds for ulcerative colitis.

Le Berre C, Roda G, Nedeljkovic Protic M, Danese S, Peyrin-Biroulet L. Le Berre C, et al. Among authors: roda g. Expert Opin Biol Ther. 2020 Apr;20(4):363-378. doi: 10.1080/14712598.2019.1666101. Epub 2019 Sep 18. Expert Opin Biol Ther. 2020. PMID: 31498003 Review.

9

Evolving therapeutic goals in ulcerative colitis: towards disease clearance.

Danese S, Roda G, Peyrin-Biroulet L. Danese S, et al. Among authors: roda g. Nat Rev Gastroenterol Hepatol. 2020 Jan;17(1):1-2. doi: 10.1038/s41575-019-0211-1. Nat Rev Gastroenterol Hepatol. 2020. PMID: 31520081 No abstract available.

10

Histological healing: should it be considered as a new outcome for ulcerative colitis?

Dal Buono A, Roda G, Argollo M, Peyrin-Biroulet L, Danese S. Dal Buono A, et al. Among authors: roda g. Expert Opin Biol Ther. 2020 Apr;20(4):407-412. doi: 10.1080/14712598.2020.1701652. Epub 2020 Jan 10. Expert Opin Biol Ther. 2020. PMID: 31847610 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters